A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)
NCT07614984
Lipoprotein(a)
Alexander City, Alabama, United States
View Trial DetailsNCT Number: NCT07177612
The goal of this observational study is to assess the if short educational videos about #LILAC-for-Lpa are feasible and accepted in improving the confidence, testing, and management on Lipoprotein(a).
Interested in participating?
Request Info16 year and older
All sexes
Observational
Online Portal, Australia, Perth, Australia
The aims of this study are to (1) assess the feasibility of using these educational videos about LILAC-for-Lp(a) to help improve confidence, testing and the management of Lp(a), (2) assess the acceptability in using short education videos about LILAC-for-Lp(a) and (3) to understand the knowledge gaps of Lp(a) in medical professionals through the additional questionnaire provided.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From enrolment to 3 months after
Survey and questionnaire on participants to assess knowledge and awareness
Time frame: From point of enrolment to 3 months
Survey to determine if the educational videos are useful for them
Time frame: During enrolment to 1 year
Survey to doctors on whether they are testing for Lipoprotein(a) in their patients prior to watching the educational videos, 3 months after, and 1 year after.
Changi General Hospital
Other
Acronym: LILAC-UNI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07614984
Lipoprotein(a)
Alexander City, Alabama, United States
View Trial DetailsNCT07613294
Arterial Occlusive Diseases, Arteriosclerosis
La Jolla, California, United States
View Trial DetailsNCT07577609
AI (Artificial Intelligence), Arterial Occlusive Diseases
Galway, Ireland
View Trial DetailsNCT07382414
Arterial Occlusive Diseases, Arteriosclerosis
Hellerup, Region Sjælland, Denmark
View Trial Details